ATP Inhibits the Transcription Factor STAT5b

被引:6
|
作者
Berg, Angela [1 ]
Sperl, Bianca [2 ]
Berg, Thorsten [1 ]
机构
[1] Univ Leipzig, Inst Organ Chem, Johannisallee 29, D-04103 Leipzig, Germany
[2] Max Planck Inst Biochem, Dept Mol Biol, Klopferspitz 18, D-82152 Martinsried, Germany
关键词
bioactive compounds; inhibitors; nucleotides; protein-protein interactions; SH2; domain; SIGNAL TRANSDUCER; SELECTIVE INHIBITORS; DISCOVERY; ACTIVATOR; CANCER; MODULATORS; DOMAINS; TARGETS; POTENT; ASSAY;
D O I
10.1002/cbic.201900173
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although naturally occurring low-molecular-weight compounds have many known roles within the cell, these do not usually involve the direct inhibition of protein-protein interactions. Based on the results of high-throughput screening of a library of bioactive compounds and neurotransmitters, we report here that the four nucleoside triphosphates ATP, GTP, CTP and UTP inhibit the SH2 domain of the tumor-related transcription factor STAT5b. ATP and GTP are the most active nucleoside triphosphates and show specificity for STAT5b over STAT5a, STAT3, STAT6 and the p53-binding protein HDM2. As the inhibition constant of ATP against STAT5b is significantly lower than published values for the intracellular ATP concentration, our data suggest that ATP might inhibit the protein-protein interactions of STAT5b in living cells.
引用
收藏
页码:2227 / 2231
页数:5
相关论文
共 50 条
  • [41] Biologic Activity of STAT5A and STAT5B in Waldenstrom's Macroglobulinemia.
    Hodge, Lucy S.
    Ziesmer, Steven C.
    Secreto, Frank J.
    Yang, Zhi-Zhang
    Novak, Anne J.
    Ansell, Stephen M.
    BLOOD, 2012, 120 (21)
  • [42] Identification of STAT5A and STAT5B Target Genes in Human T Cells
    Kanai, Takahiro
    Seki, Scott
    Jenks, Jennifer A.
    Kohli, Arunima
    Kawli, Trupti
    Martin, Dorrelyn Patacsil
    Snyder, Michael
    Bacchetta, Rosa
    Nadeau, Kari C.
    PLOS ONE, 2014, 9 (01):
  • [43] 信号转导和转录激活子5b(STAT5b)及其STAT5b基因的研究进展
    赵秀华
    李满雨
    许珊珊
    刘国君
    黑龙江农业科学, 2014, (09) : 154 - 156
  • [44] STAT5b as a novel target in human pancreatic cancer
    Lang, S. A.
    Ruemmele, P.
    Moser, C.
    Schenk, H.
    Schlitt, H. J.
    Stoeltzing, O.
    Geissler, E.
    ONKOLOGIE, 2010, 33 : 145 - 146
  • [45] STAT5b in LGL leukemia - a novel therapeutic target?
    Rajala, Hanna L. M.
    Mustjoki, Satu
    ONCOTARGET, 2013, 4 (06) : 808 - 809
  • [46] Growth hormone insensitivity associated with a STAT5b mutation
    Kofoed, EM
    Hwa, V
    Little, B
    Woods, KA
    Buckway, CK
    Tsubaki, J
    Pratt, KL
    Bezrodnik, L
    Jasper, H
    Tepper, A
    Heinrich, JJ
    Rosenfeld, RG
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (12): : 1139 - 1147
  • [47] STAT5B deficiency: Impacts on human growth and immunity
    Hwa, Vivian
    GROWTH HORMONE & IGF RESEARCH, 2016, 28 : 16 - 20
  • [48] Constitutive activation of Stat5b contributes to carcinogenesis in vivo
    Xi, SC
    Zhang, Q
    Gooding, WE
    Smithgall, TE
    Grandis, JR
    CANCER RESEARCH, 2003, 63 (20) : 6763 - 6771
  • [49] Effect of STAT5b on rat liver alcohol dehydrogenase
    Potter, JJ
    Mezey, E
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2001, 391 (01) : 41 - 48
  • [50] STAT5b: A master regulator of key biological pathways
    Smith, Madison R. R.
    Satter, Lisa R. Forbes
    Vargas-Hernandez, Alexander
    FRONTIERS IN IMMUNOLOGY, 2023, 13